FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Eva Lonn

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Geographic Areas

Canada

Procedures

Anatomy

Co-author Network

Publications

TOP 3
Michael Tsang; Eva Lonn; Suresh Perera; Hisham Dokainish
Pneumococcal endocarditis causing valve destruction in the absence of vegetations on transesophageal echocardiography: a series of 3 consecutive cases.
Billie-Jean Martin; Lawrence M Title; Subodh Verma; Francois Charbonneau; Eva Lonn; Todd J Anderson
The relationship between anthropometric indexes of adiposity and vascular function in the FATE cohort.
Todd J Anderson; André C Carpentier; Patrick Couture; Robert Dufour; Gordon A Francis; Jacques Genest; Jean Grégoire; Steven Grover; Milan Gupta; Robert A Hegele; David C W Lau; Lawrence A Leiter; Eva Lonn; G B John Mancini; Ruth McPherson; Dominic S Ng; Glen J Pearson; Paul Poirier; James A Stone; Richard Ward; Gillian M Yates; Ehud Ur
2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Eva Lonn (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Michael Tsang; Eva Lonn; Suresh Perera; Hisham Dokainish
Pneumococcal endocarditis causing valve destruction in the absence of vegetations on transesophageal echocardiography: a series of 3 consecutive cases.
The Canadian journal of cardiology 2013;29(4):519.e7-9.
2013: Billie-Jean Martin; Lawrence M Title; Subodh Verma; Francois Charbonneau; Eva Lonn; Todd J Anderson
The relationship between anthropometric indexes of adiposity and vascular function in the FATE cohort.
Obesity (Silver Spring, Md.) 2013;21(2):266-73.
2013: Todd J Anderson; André C Carpentier; Patrick Couture; Robert Dufour; Gordon A Francis; Jacques Genest; Jean Grégoire; Steven Grover; Milan Gupta; Robert A Hegele; David C W Lau; Lawrence A Leiter; Eva Lonn; G B John Mancini; Ruth McPherson; Dominic S Ng; Glen J Pearson; Paul Poirier; James A Stone; Richard Ward; Gillian M Yates; Ehud Ur
2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult.
The Canadian journal of cardiology 2013;29(2):151-67.
2011: Winnie S Su; Salim Yusuf; Jackie Bosch; Catherine M Clase; Javier Ganame; Azim S Gangji; Arsh K Jain; Eva Lonn; Peter M Margetts; Brendan McCormick; Michael Noseworthy; K Scott Brimble
The fluid study protocol: a randomized controlled study on the effects of bioimpedance analysis and vitamin D on left ventricular mass in peritoneal dialysis patients.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 2011;31(5):529-36.
2011: Gianluca Iacobellis; Eva Lonn; Andre Lamy; Navneet Singh; Arya M Sharma
Epicardial fat thickness and coronary artery disease correlate independently of obesity.
International journal of cardiology 2011;146(3):452-4.
2011: Todd J Anderson; Francois Charbonneau; Lawrence M Title; Jean Buithieu; M Sarah Rose; Heather Conradson; Kathy Hildebrand; Marinda Fung; Subodh Verma; Eva Lonn
Microvascular function predicts cardiovascular events in primary prevention: long-term results from the Firefighters and Their Endothelium (FATE) study.
Circulation 2011;123(2):163-9.
2010: Eva Lonn; Jackie Bosch; Koon K Teo; Prem Pais; Denis Xavier; Salim Yusuf
The polypill in the prevention of cardiovascular diseases: key concepts, current status, challenges, and future directions.
Circulation 2010;122(20):2078-88.
2010: Vineet Bhan; Raymond T Yan; Lawrence A Leiter; David Fitchett; Anatoly Langer; Eva Lonn; Mary Tan; Stewart Silagy; Shaun G Goodman; Andrew T Yan
Relation between obesity and the attainment of optimal blood pressure and lipid targets in high vascular risk outpatients.
The American journal of cardiology 2010;106(9):1270-6.
2010: Robert Clarke; Jim Halsey; Sarah Lewington; Eva Lonn; Jane Armitage; JoAnn E Manson; Kaare H Bønaa; J David Spence; Ottar Nygård; Rex Jamison; J Michael Gaziano; Peter Guarino; Derrick Bennett; Fraz Mir; Richard Peto; Rory Collins
Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals.
Archives of internal medicine 2010;170(18):1622-31.
2009: Brett R Cowan; Alistair A Young; Craig Anderson; Robert N Doughty; Rungroj Krittayaphong; Eva Lonn; Thomas H Marwick; Chris M Reid; John E Sanderson; Roland E Schmieder; Koon Teo; Angela K Wadham; Stephen G Worthley; Cheuk-Man Yu; Salim Yusuf; Garry L Jennings
Left ventricular mass and volume with telmisartan, ramipril, or combination in patients with previous atherosclerotic events or with diabetes mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET]).
The American journal of cardiology 2009;104(11):1484-9.
2009: Eva Lonn; Salim Yusuf
Polypill: the evidence and the promise.
Current opinion in lipidology 2009;20(6):453-9.
2009: Raymond T Yan; Andrew T Yan; Todd J Anderson; Jean Buithieu; Francois Charbonneau; Lawrence Title; Subodh Verma; Eva Lonn
The differential association between various anthropometric indices of obesity and subclinical atherosclerosis.
Atherosclerosis 2009;207(1):232-8.
2009: Jacques Genest; Ruth McPherson; Jiri Frohlich; Todd Anderson; Norm Campbell; André Carpentier; Patrick Couture; Robert Dufour; George Fodor; Gordon A Francis; Steven Grover; Milan Gupta; Robert A Hegele; David C Lau; Lawrence Leiter; Gary F Lewis; Eva Lonn; G B John Mancini; Dominic Ng; Glen Pearson; Allan Sniderman; James A Stone; Ehud Ur
2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations.
The Canadian journal of cardiology 2009;25(10):567-79.
2009: Brett R Cowan; Alistair A Young; Craig Anderson; Robert N Doughty; Rungroj Krittayaphong; Eva Lonn; Thomas H Marwick; Chris M Reid; John E Sanderson; Roland E Schmieder; Koon Teo; Angela K Wadham; Stephen G Worthley; Cheuk-Man Yu; Salim Yusuf; Garry L Jennings
The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: analysis protocol and baseline characteristics.
Clinical research in cardiology : official journal of the German Cardiac Society 2009;98(7):421-33.
2009: Glen Sumner; Omid Salehian; Qilong Yi; Jeff Healey; James Mathew; Khalid Al-Merri; Khaled Al-Nemer; J F E Mann; Gilles R Dagenais; Eva Lonn
The prognostic significance of bundle branch block in high-risk chronic stable vascular disease patients: a report from the HOPE trial.
Journal of cardiovascular electrophysiology 2009;20(7):781-7.
2009: Eva Lonn; Hertzel C Gerstein; Patrick Sheridan; Sandra Smith; Rafael Diaz; Viswanathan Mohan; Jackie Bosch; Salim Yusuf; Gilles R Dagenais
Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone).
Journal of the American College of Cardiology 2009;53(22):2028-35.
2009: Andrew C Philpott; Eva Lonn; Lawrence M Title; Subodh Verma; Jean Buithieu; Francois Charbonneau; Todd J Anderson
Comparison of new measures of vascular function to flow mediated dilatation as a measure of cardiovascular risk factors.
The American journal of cardiology 2009;103(11):1610-5.
2009: Monica Gianni; Francesco Dentali; Eva Lonn
5 flourouracil-induced apical ballooning syndrome: a case report.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2009;20(4):306-8.
2009: Salim Yusuf; Eva Lonn; Jackie Bosch
Lipid lowering for primary prevention.
Lancet 2009;373(9670):1152-5.
2009: Francesco Dentali; Marco Donadini; Monica Gianni; Andrea Bertolini; Eva Lonn; achille venco; Gianpaolo Cattozzo; Walter Ageno
Brain natriuretic peptide as a preclinical marker of chronic pulmonary hypertension in patients with pulmonary embolism.
Internal and emergency medicine 2009;4(2):123-8.
2009: Gustavo Saposnik; Joel G Ray; Patrick Sheridan; Matthew McQueen; Eva Lonn
Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial.
Stroke; a journal of cerebral circulation 2009;40(4):1365-72.
2009: Adefowope Odueyungbo; Marek Smieja; Lehana Thabane; Fiona Smaill; Kevin Gough; John Gill; Todd Anderson; Dawn Elston; Sandy Smith; Joseph Beyene; Eva Lonn
Comparison of brachial and carotid artery ultrasound for assessing extent of subclinical atherosclerosis in HIV: a prospective cohort study.
AIDS research and therapy 2009;6():11.
2008: Claes Held; Glen Sumner; Patrick Sheridan; Mathew McQueen; Sandra Smith; Gilles Dagenais; Salim Yusuf; Eva Lonn
Correlations between plasma homocysteine and folate concentrations and carotid atherosclerosis in high-risk individuals: baseline data from the Homocysteine and Atherosclerosis Reduction Trial (HART).
Vascular medicine (London, England) 2008;13(4):245-53.
2008: Todd Anderson; Francois Charbonneau; Sammy Chan; Eva Lonn
The effect of large unilamellar vesicles on vascular function in patients with coronary atherosclerosis.
Atherosclerosis 2008;200(2):424-31.
2008: Jasmine Grewal; Robert S McKelvie; Hans Persson; Peter Tait; Jonas Carlsson; Karl Swedberg; Jan Ostergren; Eva Lonn
Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
The American journal of cardiology 2008;102(6):733-7.
2008: Eva Lonn
Homocysteine-lowering B vitamin therapy in cardiovascular prevention--wrong again?
JAMA : the journal of the American Medical Association 2008;299(17):2086-7.
2008: Gilles R Dagenais; H C Gerstein; R Holman; A Budaj; A Escalante; T Hedner; Mátyás Keltai; Eva Lonn; S McFarlane; M McQueen; K Teo; P Sheridan; J Bosch; J Pogue; Salim Yusuf
Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.
Diabetes care 2008;31(5):1007-14.
2008: Jasmine Grewal; Robert S McKelvie; Eva Lonn; Peter Tait; Jonas Carlsson; Monica Gianni; Christina Jarnert; Hans Persson
BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction.
European journal of heart failure 2008;10(3):252-9.
2008: Jasmine Grewal; Sonia Anand; Shofiqul Islam; Eva Lonn
Prevalence and predictors of subclinical atherosclerosis among asymptomatic "low risk" individuals in a multiethnic population.
Atherosclerosis 2008;197(1):435-42.
2008: Francois Charbonneau; Todd J Anderson; Lawrence M Title; Jean Jobin; Paul Poirier; Thao Huyhn; Sammy Chan; Ann Walling; Stuart Hutchison; Thang Tran; Eva Lonn; Jean Buithieu; Jacques Genest
Modulation of arterial reactivity using amlodipine and atorvastatin measured by ultrasound examination (MARGAUX).
Atherosclerosis 2008;197(1):420-7.
2008: Kofo O Ogunyankin; Andrew G Day; Eva Lonn
Cardiac function stratification based on echocardiographic or clinical markers of left ventricular filling pressures predicts death and hospitalization better than stratification by ventricular systolic function alone.
Echocardiography (Mount Kisco, N.Y.) 2008;25(2):169-81.
2008: James H Stein; Claudia E Korcarz; R Todd Hurst; Eva Lonn; Christopher B Kendall; Emile R Mohler; Samer S Najjar; Christopher M Rembold; Wendy S Post
Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine.
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2008;21(2):93-111; quiz 189-90.
2008: Anwar T Merchant; Linda E Kelemen; Lawrence de Koning; Eva Lonn; Vladimir Vuksan; Ruby Jacobs; Bonnie Davis; Koon K Teo; Salim Yusuf; Sonia S Anand
Interrelation of saturated fat, trans fat, alcohol intake, and subclinical atherosclerosis.
The American journal of clinical nutrition 2008;87(1):168-74.
2007: Joel G Ray; Eva Lonn; Qilong Yi; A Rathe; Patrick Sheridan; Clive Kearon; Salim Yusuf; M J O Arnold; Matthew J McQueen; J Pogue; Jeffrey L Probstfield; George Fodor; C Held; Mary Micks; J Genest
Venous thromboembolism in association with features of the metabolic syndrome.
QJM : monthly journal of the Association of Physicians 2007;100(11):679-84.
2007: Anna M Sawka; Joel G Ray; Qilong Yi; Robert G Josse; Eva Lonn
Randomized clinical trial of homocysteine level lowering therapy and fractures.
Archives of internal medicine 2007;167(19):2136-9.
2007: Eva Lonn
Homocysteine in the prevention of ischemic heart disease, stroke and venous thromboembolism: therapeutic target or just another distraction?
Current opinion in hematology 2007;14(5):481-7.
2007: Omid Salehian; Jeff Healey; Bruce S Stambler; Khalid Alnemer; Khalid Almerri; John Grover; Iqbal Bata; Johannes Mann; James Matthew; Janice Pogue; Salim Yusuf; Gilles R Dagenais; Eva Lonn
Impact of ramipril on the incidence of atrial fibrillation: results of the Heart Outcomes Prevention Evaluation study.
American heart journal 2007;154(3):448-53.
2007: Norman R C Campbell; Donald W McKay; Heather E Conradson; Eva Lonn; Lawrence M Title; T Anderson
Automated oscillometric blood pressure versus auscultatory blood pressure as a predictor of carotid intima-medial thickness in male firefighters.
Journal of human hypertension 2007;21(7):588-90.
2007: Joel G Ray; Clive Kearon; Qilong Yi; Patrick Sheridan; Eva Lonn
Homocysteine-lowering therapy and risk for venous thromboembolism: a randomized trial.
Annals of internal medicine 2007;146(11):761-7.
2007: Monica Gianni; Jackie Bosch; Janice Pogue; Jeffrey L Probstfield; Gilles Dagenais; Salim Yusuf; Eva Lonn
Effect of long-term ACE-inhibitor therapy in elderly vascular disease patients.
European heart journal 2007;28(11):1382-8.
2007: Hans Persson; Eva Lonn; Magnus Edner; Lawrence Baruch; Chim C Lang; John J Morton; Jan Ostergren; Robert S McKelvie
Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the CHARM Echocardiographic Substudy-CHARMES.
Journal of the American College of Cardiology 2007;49(6):687-94.
2007: Richard Whitlock; Robin Evans; Eva Lonn; Kevin Teoh
Giant left atrial myxoma and associated mitral valve pathology.
Journal of cardiothoracic and vascular anesthesia 2007;21(1):103-5.
2006: Gilles R Dagenais; Janice Pogue; Koon K Teo; Eva Lonn; Salim Yusuf
Impact of ramipril on the circadian periodicity of acute myocardial infarction.
The American journal of cardiology 2006;98(6):758-60.
2006: Stefan Blankenberg; Matthew J McQueen; Marek Smieja; Janice Pogue; Cynthia Balion; Eva Lonn; Hans J Rupprecht; Christoph Bickel; Laurence Tiret; François Cambien; Hertzel C Gerstein; Thomas Münzel; Salim Yusuf
Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.
Circulation 2006;114(3):201-8.
2006: Eva Lonn; Jasmine Grewal
Drug therapies in the secondary prevention of cardiovascular diseases: Successes, shortcomings and future directions.
Current vascular pharmacology 2006;4(3):253-68.
2006: Monica Gianni; Francesco Dentali; Anna Grandi; Glen Sumner; Rajesh Hiralal; Eva Lonn
Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review.
European heart journal 2006;27(13):1523-9.
2006: Leanne M Yunker; Jillian S Parboosingh; Heather E Conradson; Peter Faris; Peter J Bridge; Jean Buithieu; Lawrence M Title; Francois Charbonneau; Subodh Verma; Eva Lonn; Todd J Anderson
The effect of iron status on vascular health.
Vascular medicine (London, England) 2006;11(2):85-91.
2006: Eva Lonn; Salim Yusuf; Malcolm J Arnold; Patrick Sheridan; Janice Pogue; Mary Micks; Matthew J McQueen; Jeffrey L Probstfield; George Fodor; Claes Held; Jacques Genest
Homocysteine lowering with folic acid and B vitamins in vascular disease.
The New England journal of medicine 2006;354(15):1567-77.
2006: Eva Lonn; C Held; J Malcolm O Arnold; Jeffrey L Probstfield; Matthew McQueen; Mary Micks; Janice Pogue; Patrick Sheridan; Jackie Bosch; J Genest; Salim Yusuf
Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trial.
The Canadian journal of cardiology 2006;22(1):47-53.
2005: Jocelyn Dupuis; Jean-Claude Tardif; Jean-Lucien Rouleau; Joseph Ricci; Malcolm Arnold; Eva Lonn; René Roux; Lawrence M Title; Robert Amyot; Nickie Bonafede; Anna Woo; Christopher P Cannon
Intensity of lipid lowering with statins and brachial artery vascular endothelium reactivity after acute coronary syndromes (from the BRAVER trial).
The American journal of cardiology 2005;96(9):1207-13.
2005: Martin H Strauss; Eva Lonn; Subodh Verma
Is the jury out? Class specific differences on coronary outcomes with ACE-inhibitors and ARBs: insight from meta-analysis and The Blood Pressure Lowering Treatment Trialists' Collaboration.
European heart journal 2005;26(22):2351-3.
2005: Subodh Verma; Chao-Hung Wang; Shu-Hong Li; Eva Lonn; Francois Charbonneau; Lawrence M Title; Todd J Anderson
The relationship between soluble CD40 ligand levels and Framingham coronary heart disease risk score in healthy volunteers.
Atherosclerosis 2005;182(2):361-5.
2005: Hertzel C Gerstein; Janice Pogue; Johannes F E Mann; Eva Lonn; Gilles R Dagenais; Matthew McQueen; Salim Yusuf
The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis.
Diabetologia 2005;48(9):1749-55.
2005: Jackie Bosch; Eva Lonn; Janice Pogue; J Malcolm O Arnold; Gilles R Dagenais; Salim Yusuf
Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension.
Circulation 2005;112(9):1339-46.
2005: Jeff S Healey; Eugene Crystal; Andre Lamy; Kevin Teoh; Lloyd Semelhago; Stefan H Hohnloser; Irene Cybulsky; Labib Abouzahr; Corey Sawchuck; Sandra Carroll; Carlos A Morillo; Peter Kleine; Victor Chu; Eva Lonn; Stuart J Connolly
Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke.
American heart journal 2005;150(2):288-93.
2005: Subodh Verma; Lawrence A Leiter; Eva Lonn; Martin H Strauss
Perindopril in diabetes: perspective from the EUROPA substudy, PERSUADE.
European heart journal 2005;26(14):1347-9.
2005: Raymond T Yan; Todd J Anderson; Francois Charbonneau; Lawrence M Title; Subodh Verma; Eva Lonn
Relationship between carotid artery intima-media thickness and brachial artery flow-mediated dilation in middle-aged healthy men.
Journal of the American College of Cardiology 2005;45(12):1980-6.
2005: Jasmine Grewal; Eva Lonn
Surrogates of surrogates: the story of hypertension and 24 h blood pressure monitoring.
The Canadian journal of cardiology 2005;21(8):639-42.
2005: Eva Lonn; Jackie Bosch; Salim Yusuf; Patrick Sheridan; Janice Pogue; J Malcolm O Arnold; Catherine Ross; Andrew Arnold; Peter Sleight; Jeffrey L Probstfield; Gilles R Dagenais
Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2005;293(11):1338-47.
2005: Milan Gupta; Eva Lonn; Subodh Verma
Should patients with stable coronary artery disease be treated with ACE inhibitor therapy?
Nature clinical practice. Cardiovascular medicine 2005;2(3):124-5.
2005: Johannes F E Mann; Qi-Long Yi; Peter Sleight; G R Dagenais; Hertzel C Gerstein; Eva Lonn; J Bosch
Serum potassium, cardiovascular risk, and effects of an ACE inhibitor: results of the HOPE study.
Clinical nephrology 2005;63(3):181-7.
2005: Gilles R Dagenais; Qilong Yi; Eva Lonn; Peter Sleight; Jan Ostergren; Salim Yusuf
Impact of cigarette smoking in high-risk patients participating in a clinical trial. A substudy from the Heart Outcomes Prevention Evaluation (HOPE) trial.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2005;12(1):75-81.
2005: Jean-Francois Dorval; Todd Anderson; Jean Buithieu; Sammy Chan; Stuart Hutchison; thao huynh; Jean Jobin; Eva Lonn; Paul Poirier; Lawrence M Title; Ann Walling; Thang Tran; Ghyslain Boudreau; Francois Charbonneau; Jacques Genest
Reaching recommended lipid and blood pressure targets with amlodipine/atorvastatin combination in patients with coronary heart disease.
The American journal of cardiology 2005;95(2):249-53.
2005: Matthew J McQueen; Eva Lonn; Hertzel C Gerstein; J Bosch; Salim Yusuf
The HOPE (Heart Outcomes Prevention Evaluation) Study and its consequences.
Scandinavian journal of clinical and laboratory investigation. Supplementum 2005;240():143-56.
2004: Andrew P Levy; Hertzel C Gerstein; Rachel Miller-Lotan; Robert Ratner; Matthew McQueen; Eva Lonn; Janice Pogue
The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes.
Diabetes care 2004;27(11):2767.
2004: Subodh Verma; Chao-Hung Wang; Eva Lonn; Francois Charbonneau; Jean Buithieu; Lawrence M Title; Marinda Fung; Steven M Edworthy; Annette C Robertson; Todd J Anderson
Cross-sectional evaluation of brachial artery flow-mediated vasodilation and C-reactive protein in healthy individuals.
European heart journal 2004;25(19):1754-60.
2004: Linda E Kelemen; Sonia S Anand; Robert A Hegele; Meir J Stampfer; Bernard Rosner; Walter C Willett; Patty Montague; Eva Lonn; Vladimir Vuksan; Koon K Teo; Sudarshan Devanesen; Salim Yusuf
Associations of plasma homocysteine and the methylenetetrahydrofolate reductase C677T polymorphism with carotid intima media thickness among South Asian, Chinese and European Canadians.
Atherosclerosis 2004;176(2):361-70.
2004: Eva Lonn
The clinical relevance of pharmacological blood pressure lowering mechanisms.
The Canadian journal of cardiology 2004;20 Suppl B():83B-88B.
2004: Sonia S Anand; Fahad Razak; Qilong Yi; Bonnie Davis; Ruby Jacobs; Vladimir Vuksan; Eva Lonn; Koon Teo; Matthew McQueen; Salim Yusuf
C-reactive protein as a screening test for cardiovascular risk in a multiethnic population.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(8):1509-15.
2004: Eva Lonn; Roya Shaikholeslami; Qilong Yi; Jackie Bosch; Brian Sullivan; Paul Tanser; Alison Magi; Salim Yusuf
Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction: a substudy of the Heart Outcomes Prevention Evaluation (HOPE) Trial.
Journal of the American College of Cardiology 2004;43(12):2200-6.
2004: Michael Theal; Khalid Sleik; Sonia Anand; Qilong Yi; Salim Yusuf; Eva Lonn
Prevalence of mitral valve prolapse in ethnic groups.
The Canadian journal of cardiology 2004;20(5):511-5.
2004: Johannes F E Mann; Eva Lonn; Qilong Yi; Hertzel C Gerstein; Byron J Hoogwerf; Janice Pogue; Jackie Bosch; Gilles R Dagenais; Salim Yusuf
Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE study.
Kidney international 2004;65(4):1375-80.
2003: Eva Lonn; James Mathew; Janice Pogue; David Johnstone; Kola Danisa; Jackie Bosch; Michael Baird; Gilles R Dagenais; Peter Sleight; Salim Yusuf
Relationship of electrocardiographic left ventricular hypertrophy to mortality and cardiovascular morbidity in high-risk patients.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2003;10(6):420-8.
2003: Gilles R Dagenais; Pierre Auger; Peter Bogaty; Hertzel Gerstein; Eva Lonn; Qilong Yi; Salim Yusuf
Increased occurrence of diabetes in people with ischemic cardiovascular disease and general and abdominal obesity.
The Canadian journal of cardiology 2003;19(12):1387-91.
2003: Johannes F E Mann; Hertzel C Gerstein; Qi-Long Yi; Jörg Franke; Eva Lonn; Byron J Hoogwerf; Andrew Rashkow; Salim Yusuf
Progression of renal insufficiency in type 2 diabetes with and without microalbuminuria: results of the Heart Outcomes and Prevention Evaluation (HOPE) randomized study.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;42(5):936-42.
2003: Theodore E Warkentin; Jane C Moore; Sonia S Anand; Eva Lonn; David G Morgan
Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand syndrome.
Transfusion medicine reviews 2003;17(4):272-86.
2003: Sonia S Anand; Qilong Yi; Hertzel C Gerstein; Eva Lonn; Ruby Jacobs; Vladimir Vuksan; Koon Teo; Bonnie Davis; Patty Montague; Salim Yusuf
Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease.
Circulation 2003;108(4):420-5.
2003: Johannes F E Mann; Hertzel C Gerstein; Ioana Dulau-Florea; Eva Lonn
Cardiovascular risk in patients with mild renal insufficiency.
Kidney international. Supplement 2003;(84):S192-6.
2003: J Malcolm O Arnold; Salim Yusuf; James Young; James Mathew; David Johnstone; Alvaro Avezum; Eva Lonn; Janice Pogue; Jackie Bosch
Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study.
Circulation 2003;107(9):1284-90.
2003: Johannes F E Mann; Hertzel C Gerstein; Qi-Long Yi; Eva Lonn; Byron J Hoogwerf; Andrew Rashkow; Salim Yusuf
Development of renal disease in people at high cardiovascular risk: results of the HOPE randomized study.
Journal of the American Society of Nephrology : JASN 2003;14(3):641-7.
2003: Marek Smieja; Judy Gnarpe; Eva Lonn; Håkan Gnarpe; Gunnar Olsson; Qilong Yi; Vladimir Dzavik; Matthew McQueen; Salim Yusuf
Multiple infections and subsequent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.
Circulation 2003;107(2):251-7.
2003: Todd J Anderson; Annette C Roberts; Kathy Hildebrand; Heather E Conradson; Charlotte Jones; Peter J Bridge; Steven M Edworthy; Eva Lonn; Subodh Verma; Francois Charbonneau
The fate of endothelial function testing: rationale and design of the Firefighters And Their Endothelium (FATE) study.
The Canadian journal of cardiology 2003;19(1):61-6.
2003: Eugene Crystal; Andre Lamy; Stuart J Connolly; Peter Kleine; Stefan H Hohnloser; Lloyd Semelhago; Labib Abouzhar; Irene Cybulsky; Bernard Shragge; Kevin Teoh; Eva Lonn; Corey Sawchuk; Feycan Oezaslan
Left Atrial Appendage Occlusion Study (LAAOS): a randomized clinical trial of left atrial appendage occlusion during routine coronary artery bypass graft surgery for long-term stroke prevention.
American heart journal 2003;145(1):174-8.
2003: Hertzel C Gerstein; Sonia Anand; Qi Long Yi; Vladimir Vuksan; Eva Lonn; Koon Teo; Klas Malmberg; Matthew McQueen; Salim Yusuf
The relationship between dysglycemia and atherosclerosis in South Asian, Chinese, and European individuals in Canada: a randomly sampled cross-sectional study.
Diabetes care 2003;26(1):144-9.
2002: Cathie Sudlow; Eva Lonn; Michael Pignone; Andy Ness; Charanjit S Rihal
Secondary prevention of ischaemic cardiac events.
Clinical evidence 2002;(8):129-68.
2002: Eva Lonn; Salim Yusuf; Byron J Hoogwerf; Janice Pogue; Qilong Yi; Bernard Zinman; Jackie Bosch; Gilles R Dagenais; Johannes F E Mann; Hertzel C Gerstein
Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy.
Diabetes care 2002;25(11):1919-27.
2002: Eva Lonn
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in atherosclerosis.
Current atherosclerosis reports 2002;4(5):363-72.
2002: Eva Lonn; Rosa Roccaforte; Qilong Yi; Gilles R Dagenais; Peter Sleight; Jackie Bosch; Pamela Suhan; Mary Micks; Jeffrey L Probstfield; Victoria Bernstein; Salim Yusuf
Effect of long-term therapy with ramipril in high-risk women.
Journal of the American College of Cardiology 2002;40(4):693-702.
2002: Cathie Sudlow; Eva Lonn; Michael Pignone; Andy Ness; Charanjit S Rihal
Secondary prevention of ischaemic cardiac events.
Clinical evidence 2002;(7):124-60.
2002: Matthew Eric Hyndman; Howard G Parsons; Subodh Verma; Peter J Bridge; Steven M Edworthy; Charlotte Jones; Eva Lonn; Francois Charbonneau; Todd J Anderson
The T-786-->C mutation in endothelial nitric oxide synthase is associated with hypertension.
Hypertension 2002;39(4):919-22.
2002: Jackie Bosch; Salim Yusuf; Janice Pogue; Peter Sleight; Eva Lonn; Badrudin Rangoonwala; Richard Davies; Jan Ostergren; Jeffrey L Probstfield
Use of ramipril in preventing stroke: double blind randomised trial.
BMJ (Clinical research ed.) 2002;324(7339):699-702.
2002: Victor J Dzau; Kenneth Bernstein; David S Celermajer; Jerome Cohen; Björn Dahlöf; John Deanfield; Javier Diez; Helmut Drexler; Roberto Ferrari; Wiek H van Gilst; Lennart Hansson; Burkhard Hornig; Ahsan Husain; Colin Johnston; Harold Lazar; Eva Lonn; Thomas Lüscher; John Mancini; Albert Mimran; Carl Pepine; Ton Rabelink; Willem Remme; Luis M Ruilope; Marcel Ruzicka; Heribert Schunkert; Karl Swedberg; Thomas Unger; Douglas Vaughan; Michael Weber
Pathophysiologic and therapeutic importance of tissue ACE: a consensus report.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2002;16(2):149-60.
2002: Johannes F E Mann; Hertzel C Gerstein; Janice Pogue; Eva Lonn; Salim Yusuf
Cardiovascular risk in patients with early renal insufficiency: implications for the use of ACE inhibitors.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2002;2(3):157-62.
2001: Victor J Dzau; K Bernstein; David S Celermajer; J Cohen; B Dahlöf; John Deanfield; J Diez; Helmut Drexler; R Ferrari; Wiek H van Gilst; L Hansson; B Hornig; A Husain; C Johnston; H Lazar; Eva Lonn; T Lüscher; J Mancini; Albert Mimran; Carl Pepine; T Rabelink; W Remme; Luis M Ruilope; M Ruzicka; Heribert Schunkert; K Swedberg; T Unger; D Vaughan; M Weber
The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data.
The American journal of cardiology 2001;88(9A):1L-20L.
2001: Eva Lonn
Epidemiology of ischemic heart disease in women.
The Canadian journal of cardiology 2001;17 Suppl D():14D-23D.
2001: Sonia S Anand; Salim Yusuf; Ruby Jacobs; A D Davis; Qilong Yi; Hertzel C Gerstein; Patty Montague; Eva Lonn
Risk factors, atherosclerosis, and cardiovascular disease among Aboriginal people in Canada: the Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP).
Lancet 2001;358(9288):1147-53.
2001: J Mathew; Peter Sleight; Eva Lonn; David E Johnstone; Janice Pogue; Qilong Yi; Jackie Bosch; Bruce Sussex; Jeffrey L Probstfield; Salim Yusuf
Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril.
Circulation 2001;104(14):1615-21.
2001: Eva Lonn
Use of carotid ultrasound to stratify risk.
The Canadian journal of cardiology 2001;17 Suppl A():22A-5A.
2001: Eva Lonn; Salim Yusuf; Vladimir Dzavik; C Doris; Qilong Yi; S Smith; A Moore-Cox; Jackie Bosch; W Riley; Koon Teo
Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE).
Circulation 2001;103(7):919-25.
2001: Eva Lonn
Antiatherosclerotic effects of ACE inhibitors: where are we now?
American journal of cardiovascular drugs : drugs, devices, and other interventions 2001;1(5):315-20.
2001: Eva Lonn
Modifying the natural history of atherosclerosis: the SECURE trial.
International journal of clinical practice. Supplement 2001;(117):13-8.
2000: Sonia S Anand; Salim Yusuf; Vladimir Vuksan; Sudarshan Devanesen; Koon K Teo; Patty Montague; Linda E Kelemen; C Yi; Eva Lonn; Hertzel C Gerstein; Robert A Hegele
Differences in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada: the study of health assessment and risk in ethnic groups (SHARE).
Indian heart journal 2000;52(7 Suppl):S35-43.
2000: Sonia S Anand; Salim Yusuf; Vladimir Vuksan; Sudarshan Devanesen; Koon K Teo; Patty Montague; Linda E Kelemen; C Yi; Eva Lonn; Hertzel C Gerstein; Robert A Hegele; Matthew McQueen
Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)
Lancet 2000;356(9226):279-84.
2000: Jacques Genest; M C Audelin; Eva Lonn
Homocysteine: to screen and treat or to wait and see?
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2000;163(1):37-8.
1999: K Salem; Amin Mulji; Eva Lonn
Echocardiographically guided pericardiocentesis - the gold standard for the management of pericardial effusion and cardiac tamponade.
The Canadian journal of cardiology 1999;15(11):1251-5.
1999: John W Eikelboom; Eva Lonn; J Genest; Graeme J Hankey; Salim Yusuf
Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence.
Annals of internal medicine 1999;131(5):363-75.
1999: Salim Yusuf; Eva Lonn; J Bosch; Hertzel C Gerstein
Summary of randomized trials of angiotensin converting enzyme inhibitors.
Clinical and experimental hypertension (New York, N.Y. : 1993) 1999;21(5-6):835-45.
1998: Sonia S Anand; Salim Yusuf; Vladimir Vuksan; Sudarshan Devanesen; Patty Montague; Linda E Kelemen; Jackie Bosch; Christopher Sigouin; Koon K Teo; Eva Lonn; Hertzel C Gerstein; Robert A Hegele; Matthew McQueen
The Study of Health Assessment and Risk in Ethnic groups (SHARE): rationale and design. The SHARE Investigators.
The Canadian journal of cardiology 1998;14(11):1349-57.
1998: Salim Yusuf; Eva Lonn
Anti-ischaemic effects of ACE inhibitors: review of current clinical evidence and ongoing clinical trials.
European heart journal 1998;19 Suppl J():J36-44.
1997: Eva Lonn; Salim Yusuf
Is there a role for antioxidant vitamins in the prevention of cardiovascular diseases? An update on epidemiological and clinical trials data.
The Canadian journal of cardiology 1997;13(10):957-65.
1997: Eva Lonn
Aggressive as opposed to moderate low-density lipoprotein cholesterol lowering strategies reduced the progression of atherosclerosis in grafts and reduced further revascularization.
Evidence-based cardiovascular medicine 1997;1(2):49.
1996: Eva Lonn; Salim Yusuf; C I Doris; M J Sabine; V Dzavik; K Hutchison; W A Riley; J Tucker; Janice Pogue; W Taylor
Study design and baseline characteristics of the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E: SECURE.
The American journal of cardiology 1996;78(8):914-9.
1996: G Venkatesh; Eva Lonn; D A Holder; W G Williams; A Mulji
Acquired left ventricular to right atrial communication and complete heart block following nonpenetrating cardiac trauma.
The Canadian journal of cardiology 1996;12(4):349-52.
1995: P Jha; Marcus Flather; Eva Lonn; M Farkouh; Salim Yusuf
The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data.
Annals of internal medicine 1995;123(11):860-72.
1995: M D Flather; Eva Lonn; Salim Yusuf
Effects of ACE inhibitors on mortality when started in the early phase of myocardial infarction: evidence from the larger randomized controlled trials.
Journal of cardiovascular risk 1995;2(5):423-8.
1994: Eva Lonn; Salim Yusuf; P Jha; T J Montague; Koon K Teo; C R Benedict; Bertram Pitt
Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.
Circulation 1994;90(4):2056-69.
1993: Salim Yusuf; J Lessem; P Jha; Eva Lonn
Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trials.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1993;11(4):S61-73.